| DB11595 | Atezolizumab | approved, investigational | yes | inhibitorantibody | Details |
| DB11945 | Avelumab | approved, investigational | yes | inhibitorantibody | Details |
| DB11714 | Durvalumab | approved, investigational | yes | inhibitorantibody | Details |
| DB15769 | Envafolimab | investigational | unknown | inhibitorantibody | Details |
| DB15770 | Cosibelimab | investigational | unknown | inhibitorantibody | Details |
| DB15771 | AUNP-12 | investigational | unknown | inhibitorantibody | Details |
| DB15772 | CA-170 | investigational | unknown | inhibitor | Details |
| DB15773 | anti-OX40 antibody BMS 986178 | investigational | unknown | inhibitor | Details |
| DB00313 | Valproic acid | approved, investigational | unknown | downregulator | Details |
| DB00203 | Sildenafil | approved, investigational | unknown | downregulator | Details |
| DB14776 | Camrelizumab | investigational | unknown | inhibitorantibody | Details |
| DB09035 | Nivolumab | approved | unknown | inhibitorantibody | Details |
| DB09037 | Pembrolizumab | approved | unknown | inhibitorantibody | Details |